Connect to share and comment

DOJ again asks NY appeals court to delay lifting age restrictions in morning-after pill case

NEW YORK, N.Y. - Department of Justice lawyers filed court papers Friday again asking a federal appeals court to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after pill. The papers seek to delay implementation of a judge's April 5 ruling lifting restrictions on the drugs, including the medications sold under the brand name Plan B, setting the stage for another court showdown between President Barack Obama's administration and women's health activists over access to the contraceptive.

Acne pill benefits outweigh blood clot risk: EU agency

Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins -- when correctly prescribed. The clot risk was "low", said a European Medicines Agency (EMA) ruling on a French-initiated review of the drug's safety. But it stressed Diane-35 and its generics should be used only for acne treatment, as indicated by the pill's German manufacturer, Bayer.

Acne pill benefits outweigh blood clot risk: EU agency

Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins. The clot risk was "low", said a European Medicines Agency (EMA) ruling on a French-initiated review of the drug's safety. But it stressed Diane-35 and its generics should only be used when alternative acne treatments had failed and said measures must be taken to minimise the blood clot risk.

Acne pill benefits outweigh blood clot risk: EU agency

Europe's medicines watchdog said Friday the benefits of acne drug Diane-35, also widely used as a contraceptive, outweigh the risk of developing blood clots in the veins -- when correctly prescribed. The clot risk was "low", said a European Medicines Agency (EMA) ruling on a French-initiated review of the drug's safety. But it stressed Diane-35 and its generics should be used only for acne treatment, as indicated by the pill's German manufacturer, Bayer.

US government files appeal to delay unrestricted sales of morning-after pill

NEW YORK, N.Y. - The Obama administration on Monday filed a last-minute appeal to delay the sale of the morning-after contraceptive pill to girls of any age without a prescription. The legal paperwork asked the 2nd U.S. Circuit Court of Appeals in Manhattan to postpone a federal judge's ruling that eliminated age limits on the pill while the government appeals that overall decision.

On eve of Plan B ruling taking effect, NY judge refuses to delay access to morning-after pill

NEW YORK, N.Y. - A government appeal of a ruling giving women of all ages broad access to morning-after birth control is frivolous, a federal judge said Friday as he refused to suspend enforcement of his decision pending appeal. U.S. District Judge Edward Korman in Brooklyn did agree to postpone implementation of his month-old decision until Monday to give the government time to appeal to the 2nd U.S. Circuit Court of Appeals in Manhattan.

Obama comfortable with FDA decision to let 15-year-olds buy morning-after pill

By Steve Holland MEXICO CITY (Reuters) - President Barack Obama said on Thursday he is comfortable with a U.S. government agency's decision to allow over-the-counter purchases of a morning-after pill for anyone 15 and older. Some critics have complained girls that young should not be allowed to purchase the pills without a doctor's approval. But Obama told a news conference in Mexico City that the decision was based on "solid scientific evidence."

NY judge urged to reject Justice Department request to delay morning-after ruling enforcement

NEW YORK, N.Y. - Reproductive rights advocates urged a judge Monday to let teenage girls buy morning-after birth control without a prescription beginning this week, saying to delay enforcement of his ruling while the government appeals would cause "certain, significant and irreparable" harm to women.

US appeals emergency contraception ruling

The US Department of Justice appealed Wednesday a federal judge's ruling ordering regulators to provide emergency contraception to women and girls of all ages. The appeal came just one day after the Food and Drug Administration allowed a manufacturer to make the Plan B One-Step morning after pill available to those age 15 and older without a prescription. The FDA says that decision is not related to the pending court case over emergency contraception.

US approves morning-after pill for age 15 and up

US regulators have approved a brand of emergency contraception for those age 15 and up without a prescription, defying a judge's order to make the morning-after pill available to all ages. The decision by the US Food and Drug Administration to allow Plan B One-Step to be sold over the counter to some teens without a doctor's order did not go as far as a federal judge directed last month after a more than decade-long court fight.
Syndicate content